219 related articles for article (PubMed ID: 33114431)
41. Haptoglobin Hp2 Variant Promotes Premature Cardiovascular Death in Stroke Survivors.
Ijäs P; Melkas S; Saksi J; Jula A; Jauhiainen M; Oksala N; Pohjasvaara T; Kaste M; Karhunen PJ; Lindsberg P; Erkinjuntti T
Stroke; 2017 Jun; 48(6):1463-1469. PubMed ID: 28487337
[TBL] [Abstract][Full Text] [Related]
42. Intensive lifestyle intervention in type 2 diabetes and risk of incident coronary artery disease for the common haptoglobin phenotypes: the Look AHEAD study.
Warren RA; Bancks MP; Carew AS; Levy AP; Sapp J; Bahnson J; Lewis CE; Rimm EB; Espeland MA; Cahill LE
Cardiovasc Diabetol; 2024 Feb; 23(1):82. PubMed ID: 38402400
[TBL] [Abstract][Full Text] [Related]
43. Serum level of sCD163, a soluble receptor for hemoglobin, is influenced by cardiac surgery.
Kolackova M; Lonsky V; Trojackova Kudlova M; Mandak J; Kunes P; Svitek V; Jankovicova K; Vlaskova D; Andrys C; Krejsek J
Perfusion; 2009 Jul; 24(4):263-9. PubMed ID: 19808746
[TBL] [Abstract][Full Text] [Related]
44. The association of high sCD163/sTWEAK ratio with cardiovascular disease in hemodialysis patients.
Rusu CC; Racasan S; Kacso IM; Ghervan L; Moldovan D; Potra A; Patiu IM; Bondor C; Caprioara MG
Int Urol Nephrol; 2015 Dec; 47(12):2023-30. PubMed ID: 26433887
[TBL] [Abstract][Full Text] [Related]
45. Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease.
Dige A; Støy S; Thomsen KL; Hvas CL; Agnholt J; Dahlerup JF; Møller HJ; Grønbaek H
Scand J Immunol; 2014 Dec; 80(6):417-23. PubMed ID: 25346048
[TBL] [Abstract][Full Text] [Related]
46. Association between haptoglobin 2-2 genotype and coronary artery disease and its severity in a tunisian population.
Moussa A; Rejeb J; Omezzine A; Rebhi L; Boumaiza I; Kacem S; Ben Rejeb N; Boughzala E; Ben Abdelaziz A; Bouslama A
Biochem Genet; 2014 Jun; 52(5-6):269-82. PubMed ID: 24535155
[TBL] [Abstract][Full Text] [Related]
47. Impact of soluble TWEAK and CD163/TWEAK ratio on long-term cardiovascular mortality in patients with peripheral arterial disease.
Urbonaviciene G; Martin-Ventura JL; Lindholt JS; Urbonavicius S; Moreno JA; Egido J; Blanco-Colio LM
Atherosclerosis; 2011 Dec; 219(2):892-9. PubMed ID: 21962403
[TBL] [Abstract][Full Text] [Related]
48. Serum sTWEAK concentrations and risk of developing type 2 diabetes in a high cardiovascular risk population: a nested case-control study.
Díaz-López A; Chacón MR; Bulló M; Maymó-Masip E; Martínez-González MA; Estruch R; Vendrell J; Basora J; Díez-Espino J; Covas MI; Salas-Salvadó J
J Clin Endocrinol Metab; 2013 Aug; 98(8):3482-90. PubMed ID: 23760626
[TBL] [Abstract][Full Text] [Related]
49. Haptoglobin genotypes and refractory hypertension in type 2 diabetes mellitus patients.
Wobeto VP; Pinho Pda C; Souza JR; Zaccariotto TR; Zonati Mde F
Arq Bras Cardiol; 2011 Oct; 97(4):338-45. PubMed ID: 22011804
[TBL] [Abstract][Full Text] [Related]
50. Haptoglobin phenotype and risk of cervical neoplasia: a case-control study.
Mahmud SM; Koushik A; Duarte-Franco E; Costa J; Fontes G; Bicho M; Coutlée F; Franco EL;
Clin Chim Acta; 2007 Oct; 385(1-2):67-72. PubMed ID: 17706188
[TBL] [Abstract][Full Text] [Related]
51. Serum soluble CD163 predicts risk of type 2 diabetes in the general population.
Møller HJ; Frikke-Schmidt R; Moestrup SK; Nordestgaard BG; Tybjærg-Hansen A
Clin Chem; 2011 Feb; 57(2):291-7. PubMed ID: 21106861
[TBL] [Abstract][Full Text] [Related]
52. Alterations of soluble TWEAK and CD163 concentrations in patients with chronic heart failure.
Ptaszynska-Kopczynska K; Marcinkiewicz-Siemion M; Lisowska A; Waszkiewicz E; Witkowski M; Jasiewicz M; Miklasz P; Jakim P; Galar B; Musial WJ; Kaminski KA
Cytokine; 2016 Apr; 80():7-12. PubMed ID: 26916171
[TBL] [Abstract][Full Text] [Related]
53. Haptoglobin Genotype Does Not Confer a Risk of Stroke in Type 1 Diabetes.
Syreeni A; Dahlström EH; Hägg-Holmberg S; Forsblom C; Eriksson MI; Harjutsalo V; Putaala J; Groop PH; Sandholm N; Thorn LM
Diabetes; 2022 Dec; 71(12):2728-2738. PubMed ID: 36409784
[TBL] [Abstract][Full Text] [Related]
54. MicroRNA-381 reduces inflammation and infiltration of macrophages in polymyositis via downregulating HMGB1.
Liu Y; Gao Y; Yang J; Shi C; Wang Y; Xu Y
Int J Oncol; 2018 Sep; 53(3):1332-1342. PubMed ID: 29956737
[TBL] [Abstract][Full Text] [Related]
55. The Macrophage Activation Marker Soluble CD163 is Longitudinally Associated With Insulin Sensitivity and β-cell Function.
Semnani-Azad Z; Connelly PW; Johnston LW; Retnakaran R; Harris SB; Zinman B; Hanley AJ
J Clin Endocrinol Metab; 2020 Mar; 105(3):e285-94. PubMed ID: 31677389
[TBL] [Abstract][Full Text] [Related]
56. A preliminary investigation of the association between haptoglobin polymorphism, serum ferritin concentration and fatty liver disease.
Nakagawa T; Muramoto Y; Hori M; Mihara S; Marubayashi T; Nakagawa K
Clin Chim Acta; 2008 Dec; 398(1-2):34-8. PubMed ID: 18760271
[TBL] [Abstract][Full Text] [Related]
57. Reductive nitrosylation of ferric human hemoglobin bound to human haptoglobin 1-1 and 2-2.
Ascenzi P; De Simone G; Polticelli F; Gioia M; Coletta M
J Biol Inorg Chem; 2018 May; 23(3):437-445. PubMed ID: 29605886
[TBL] [Abstract][Full Text] [Related]
58. Characterization of an enzyme-linked immunosorbent assay for soluble CD163.
Møller HJ; Hald K; Moestrup SK
Scand J Clin Lab Invest; 2002; 62(4):293-9. PubMed ID: 12476928
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of serum haptoglobin levels and Hp1-Hp2 polymorphism in the haptoglobin gene in patients with atrial fibrillation.
Costa LBX; Martins GL; Duarte RCF; Rocha PL; Figueiredo EL; Silveira FR; das Graças Carvalho M; Reis HJ; Gomes KB; Ferreira CN
Mol Biol Rep; 2022 Aug; 49(8):7359-7365. PubMed ID: 35576050
[TBL] [Abstract][Full Text] [Related]
60. Haptoglobin Phenotypes Are Associated with the Postload Glucose and Insulin Levels in Pediatric Obesity.
Ricotti R; De Feudis M; Peri C; Corazzari M; Genoni G; Giordano M; Mancioppi V; Agosti E; Bellone S; Prodam F
Int J Endocrinol; 2020; 2020():6035138. PubMed ID: 32695161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
